PL3645535T3 - Nowa sól N-(2,6-dietylofenylo)-8-({4-[4-(dimetyloamino)piperydyn-1-ylo]-2-metoksyfenylo}amino)-1-metylo-4,5-dihydro-1H-pirazolo[4,3-h]chinazolino-3-karboksyamidu, jej wytwarzanie oraz kompozycje ją zawierające - Google Patents
Nowa sól N-(2,6-dietylofenylo)-8-({4-[4-(dimetyloamino)piperydyn-1-ylo]-2-metoksyfenylo}amino)-1-metylo-4,5-dihydro-1H-pirazolo[4,3-h]chinazolino-3-karboksyamidu, jej wytwarzanie oraz kompozycje ją zawierająceInfo
- Publication number
- PL3645535T3 PL3645535T3 PL18732820T PL18732820T PL3645535T3 PL 3645535 T3 PL3645535 T3 PL 3645535T3 PL 18732820 T PL18732820 T PL 18732820T PL 18732820 T PL18732820 T PL 18732820T PL 3645535 T3 PL3645535 T3 PL 3645535T3
- Authority
- PL
- Poland
- Prior art keywords
- diethylphenyl
- pyrazolo
- quinazoline
- piperidin
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305826 | 2017-06-29 | ||
| EP18732820.8A EP3645535B1 (en) | 2017-06-29 | 2018-06-28 | New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it |
| PCT/EP2018/067394 WO2019002454A1 (en) | 2017-06-29 | 2018-06-28 | NOVEL N- (2,6-DIETHYLPHENYL) -8 - ({4- [4- (DIMETHYLAMINO) PIPERIDIN-1-YL] -2-METHOXYPHENYL} AMINO) -1-METHYL-4,5-DIHYDRO-1H SALT -PYRAZOLO [4,3-H] QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3645535T3 true PL3645535T3 (pl) | 2022-03-21 |
Family
ID=59313166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18732820T PL3645535T3 (pl) | 2017-06-29 | 2018-06-28 | Nowa sól N-(2,6-dietylofenylo)-8-({4-[4-(dimetyloamino)piperydyn-1-ylo]-2-metoksyfenylo}amino)-1-metylo-4,5-dihydro-1H-pirazolo[4,3-h]chinazolino-3-karboksyamidu, jej wytwarzanie oraz kompozycje ją zawierające |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US11160806B2 (enExample) |
| EP (1) | EP3645535B1 (enExample) |
| JP (1) | JP7141416B2 (enExample) |
| KR (1) | KR102609333B1 (enExample) |
| CN (1) | CN110896636B (enExample) |
| AR (1) | AR112040A1 (enExample) |
| AU (1) | AU2018293729B9 (enExample) |
| CA (1) | CA3068357C (enExample) |
| CL (1) | CL2019003848A1 (enExample) |
| EA (1) | EA039764B1 (enExample) |
| ES (1) | ES2900048T3 (enExample) |
| IL (1) | IL271628B2 (enExample) |
| MA (1) | MA49498A (enExample) |
| PL (1) | PL3645535T3 (enExample) |
| PY (1) | PY1850855A (enExample) |
| SG (1) | SG11201912651WA (enExample) |
| TW (1) | TWI750393B (enExample) |
| UY (1) | UY37778A (enExample) |
| WO (1) | WO2019002454A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025002962A1 (en) | 2023-06-30 | 2025-01-02 | Nerviano Medical Sciences S.R.L. | Use of a mps1 inhibitor for the treatment of hepatocellular carcinoma |
| WO2025021587A1 (en) | 2023-07-21 | 2025-01-30 | Nerviano Medical Sciences S.R.L. | Combination of a mps1 inhibitor and immune checkpoint inhibitors, uses and pharmaceutical compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0914649B1 (pt) * | 2008-06-26 | 2021-07-06 | Les Laboratoires Servier | Pirazolo-quinazolinas |
-
2018
- 2018-06-21 UY UY0001037778A patent/UY37778A/es not_active Application Discontinuation
- 2018-06-28 JP JP2019572116A patent/JP7141416B2/ja active Active
- 2018-06-28 ES ES18732820T patent/ES2900048T3/es active Active
- 2018-06-28 WO PCT/EP2018/067394 patent/WO2019002454A1/en not_active Ceased
- 2018-06-28 CA CA3068357A patent/CA3068357C/en active Active
- 2018-06-28 EP EP18732820.8A patent/EP3645535B1/en active Active
- 2018-06-28 AU AU2018293729A patent/AU2018293729B9/en active Active
- 2018-06-28 EA EA202090115A patent/EA039764B1/ru unknown
- 2018-06-28 TW TW107122235A patent/TWI750393B/zh active
- 2018-06-28 CN CN201880043442.0A patent/CN110896636B/zh active Active
- 2018-06-28 SG SG11201912651WA patent/SG11201912651WA/en unknown
- 2018-06-28 AR ARP180101781A patent/AR112040A1/es unknown
- 2018-06-28 PL PL18732820T patent/PL3645535T3/pl unknown
- 2018-06-28 PY PY201801850855A patent/PY1850855A/es unknown
- 2018-06-28 MA MA049498A patent/MA49498A/fr unknown
- 2018-06-28 US US16/624,488 patent/US11160806B2/en active Active
- 2018-06-28 KR KR1020207002339A patent/KR102609333B1/ko active Active
-
2019
- 2019-12-22 IL IL271628A patent/IL271628B2/en unknown
- 2019-12-26 CL CL2019003848A patent/CL2019003848A1/es unknown
-
2021
- 2021-09-30 US US17/490,318 patent/US20220016122A1/en not_active Abandoned
-
2024
- 2024-07-01 US US18/760,494 patent/US20240350501A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2900048T3 (es) | 2022-03-15 |
| MA49498A (fr) | 2021-05-26 |
| US11160806B2 (en) | 2021-11-02 |
| KR20200020905A (ko) | 2020-02-26 |
| IL271628B1 (en) | 2023-03-01 |
| AU2018293729B9 (en) | 2022-07-14 |
| UY37778A (es) | 2019-01-31 |
| US20220016122A1 (en) | 2022-01-20 |
| CN110896636A (zh) | 2020-03-20 |
| SG11201912651WA (en) | 2020-01-30 |
| EA202090115A1 (ru) | 2020-05-25 |
| KR102609333B1 (ko) | 2023-12-01 |
| EP3645535B1 (en) | 2021-09-08 |
| PY1850855A (es) | 2019-04-01 |
| TW201904971A (zh) | 2019-02-01 |
| US20240350501A1 (en) | 2024-10-24 |
| JP2020525477A (ja) | 2020-08-27 |
| CN110896636B (zh) | 2022-07-19 |
| EA039764B1 (ru) | 2022-03-11 |
| CL2019003848A1 (es) | 2020-07-10 |
| IL271628B2 (en) | 2023-07-01 |
| US20200246339A1 (en) | 2020-08-06 |
| EP3645535A1 (en) | 2020-05-06 |
| AU2018293729B2 (en) | 2022-03-10 |
| CA3068357A1 (en) | 2019-01-03 |
| WO2019002454A1 (en) | 2019-01-03 |
| TWI750393B (zh) | 2021-12-21 |
| AR112040A1 (es) | 2019-09-11 |
| CA3068357C (en) | 2022-04-19 |
| JP7141416B2 (ja) | 2022-09-22 |
| AU2018293729A1 (en) | 2020-01-23 |
| BR112019027924A2 (pt) | 2020-08-18 |
| IL271628A (en) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289763A (en) | Compounds, pharmaceutical compounds and methods for preparing compounds and their use | |
| SG11202104460UA (en) | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors | |
| PL3889145T3 (pl) | 8-cyjano-5-piperydyno-chinoliny jako antagoniści TLR7/8 oraz ich zastosowanie w leczeniu zaburzeń immunologicznych | |
| IL285008A (en) | Methods for the production and use of myceliated amino acid-supplemented food compositions | |
| EA201990657A1 (ru) | Соединения и композиции в качестве ингибиторов эндосомальных toll-подобных рецепторов | |
| WO2015153959A3 (en) | Small molecule inhibitors of mcl-1 and uses thereof | |
| HUE049989T2 (hu) | (S)-4-(8-amino-3-(1-(but-2-inoil)pirrolidin-2-il)imidazo[1,5-a]pirazin-1-il)-N-(piridin-2-il)benzamid szilárd alakjai és készítményei | |
| EP3250572A4 (en) | Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof | |
| SG11202105730TA (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| EA201691674A1 (ru) | 1,2-замещенные циклопентаны в качестве антагонистов рецептора орексина | |
| EA201792057A1 (ru) | Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы | |
| WO2014093583A3 (en) | Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof | |
| IL279328A (en) | Methods for producing compositions of amino acids | |
| WO2014153495A9 (en) | Novel stat3 inhibitors | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| IL292682A (en) | Formulation of x842 for oral administration | |
| IL311733A (en) | Hydrochloride salt of inupdanant, pharmaceutical preparations and methods of using it | |
| EA201492029A1 (ru) | N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид | |
| IL284997A (en) | Methods for making mixed allergen compositions | |
| IL271628A (en) | A new salt of N-(6,2-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-5,4-dihydro-1H -pyrazolo[3,4-H]quinazoline-3-carboxamide, its preparation and formulations containing it | |
| NZ701428A (en) | New alfentanil composition for the treatment of acute pain | |
| IT201600122310A1 (it) | Composizione per uso nella terapia di alterazioni dell'intestino | |
| HK1238192A1 (en) | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | |
| BR112017025757A2 (pt) | formulações oftálmicas de inibidores da tirosina quinase, métodos de uso das mesmas, e métodos para a preparação das mesmas |